Mary-Elizabeth Percival, M.D., is a board certified oncology hematologist at Fred Hutchinson Cancer Center and UW Medical Center and a UW assistant professor of Hematology and Medicine.

Dr. Percival feels the UW has a strong program for the treatment of acute leukemia and she is excited to be a part of it. She is especially enthusiastic about the clinical trials available, which can potentially improve outcomes for both current and future patients with leukemia.

Dr. Percival earned her bachelor’s degree magna cum laude from Harvard and her M.D. from Stanford. She is currently a candidate for a master's degree in epidemiology and clinical research at Stanford. She is a member of the American Society of Hematology and the American Society for Clinical Oncology. Her clinical and research interests include treatment of AML and MDS, particularly using novel drugs and clinical trials.